2nd Annual Next Gen Immuno-Oncology Congress

2nd Annual Next Gen Immuno-Oncology Congress is organized by MarketsandMarkets (MnM) Research Private Ltd and will be held during Mar 13 - 14, 2018 at Thistle London Heathrow Terminal 5 hotel, London, England, United Kingdom.

The target audience for this medical event is Pharmaceutical, biopharmaceutical, biotechnology, research institutes: CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group leaders, Professor, Assistant professors, Research fellow, Ph.D. working on Antibody Drug Conjugates, Bispecific Antibodies and Cell Therapy, Immune Checkpoint Inhibitors.

Conference Description :
This congress aims to bring academicians, researchers and scientists from research institute pharmaceutical, biopharmaceutical and biotechnology companies to discuss the latest updates in the development of ADC’s, Bispecific Antibodies and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

Topics include :
• NextGen CAR-T Cell therapy
• Pre-clinical and Translational Immuno-Oncology Developments
• Check Point Inhibitors and Combination Strategies
• Novel Payloads and Linkers
• Oncolytic viruses in the era of checkpoint blockade
• Personalized Immunotherapy and Viral Therapies
• Novel concepts in Bispecific Antibodies Engineering
• Cell therapy and Vaccines
• Biomarkers for Immuno-Oncology
• Tumor Microenvironment

Additional details will be posted as soon as they are available.